OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Amazon vs. Costco: Which Stock Is a Better Buy?

Amazon vs. Costco: Which Stock Is a Better Buy?

Cross Staff Loads Up on 289,000 Shares of AKRE

Cross Staff Loads Up on 289,000 Shares of AKRE

Prediction: This Artificial Intelligence (AI) Stock Will Join Nvidia, Apple, and Alphabet in the $3 Trillion Club Before 2028

The billion-dollar infrastructure deals powering the AI boom

AI Boom May Be Creating Hidden Risks In Housing Market

Cisco’s Secure AI Factory Links Sovereign Data Push To Valuation Story

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

XTransfer Attends Brazil’s Largest E-Commerce Summit

August 13, 2025

Focusing on the Development of the Brazilian and Latin American Markets São Paulo, Brazil--(Newsfile Corp. - August 13, 2025) - XTransfer, the World's Leading...

3rdPartyFeeds

Chinese tech giant Tencent’s quarterly revenue jumps 15% on AI investments, gaming unit boost

August 13, 2025

The Chinese tech giant's newly-released "Delta Force" game and the performance of "Honor of Kings" and "Peacekeeper Elite" helped boost revenue. Read more...

The 3 Things That Matter for Viking Therapeutics Now
Uncategorized

The 3 Things That Matter for Viking Therapeutics Now

August 13, 2025

Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

Morgan Stanley Raises PT on Visa Inc. (V) to $402; Maintains ‘Overweight’ Rating
Uncategorized

Morgan Stanley Raises PT on Visa Inc. (V) to $402; Maintains ‘Overweight’ Rating

August 13, 2025

With a significant presence in Warren Buffett’s portfolio and strong hedge fund interest, Visa Inc. (NYSE:V) secures a spot on our list of the 14 Best Warren...

Perplexity Makes $34.5B Play for Google’s Chrome
Uncategorized

Perplexity Makes $34.5B Play for Google’s Chrome

August 12, 2025

DOJ wants Google to divest Chrome after antitrust ruling.

3rdPartyFeeds

CoreWeave shares drop even as revenue and guidance top estimates

August 12, 2025

CoreWeave expanded its business with OpenAI during the second quarter, and it's also working with banks Goldman Sachs and Morgan Stanley. Read more...

CoreWeave Revenue Tops Estimates On Compute Demand. Beat Smaller Than Q1.
Uncategorized

CoreWeave Revenue Tops Estimates On Compute Demand. Beat Smaller Than Q1.

August 12, 2025

CoreWeave stock fell amid second quarter revenue growth of over 200%. The revenue beat came in at 12%, smaller than Q1’s 15% beat.

3rdPartyFeeds

Cava stock plummets after company lowers forecast on disappointing same-store sales growth

August 12, 2025

Cava also announced an investment in Hyphen, a restaurant automation startup. Read more...

3rdPartyFeeds

Shares of Swiss sneaker company On jump as it posts 32% sales growth, hikes outlook

August 12, 2025

Swiss sneaker maker On posted another quarter of strong growth as it leans on innovation to drive sales. Read more...

Canary Speech Appoints Dr. Kang Hsu, Jr. as Chief Medical Officer to Lead Clinical Strategy and Expand Voice Biomarker Adoption
Uncategorized

Canary Speech Appoints Dr. Kang Hsu, Jr. as Chief Medical Officer to Lead Clinical Strategy and Expand Voice Biomarker Adoption

August 12, 2025

Canary Speech, the leading AI-powered voice biomarker health tech company, today announced the appointment of Kang Hsu, Jr., MD as its new Chief Medical...

Previous 1 … 115 116 117 118 119 … 8,454 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.